Skip to content

Evaluation of impact of Calcium Calcium Fructoborate in patients admitted with the diagnosis of COVID19 infection.

Effects of organic boron - sugar complex (as Calcium Fructoborate) supplement on the severity and consequences of COVID-19 in inpatient cases: A double blind Clinical Trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090803002276N4
Enrollment
300
Registered
2021-10-29
Start date
2021-11-01
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

covid-19. COVID-19, virus identified

Interventions

Intervention 1: Intervention group: Standard therapeutic regimen for COVID-19 and a dose of 5 milliliter of a syrup containing 430 mg Calcium fructoborate solution prepared by Arnica daru Danesh Adrin

Sponsors

Arnica darou danesh adrin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: Admission in the hospital with a positve PCR test for COVID-19 Age between 19 and 80 years

Exclusion criteria

Exclusion criteria: Patients suspected to bacterial infections in the first day of admission suffering severe chronic diseases pregnancy consumption of medications not recommended in national COVID-19 guideline.

Design outcomes

Primary

MeasureTime frame
Mortality rate. Timepoint: from including to study to 30 days. Method of measurement: Observation.;Hospital stay. Timepoint: After discharge. Method of measurement: Patient hospital record.

Secondary

MeasureTime frame
?Arterial Oxygen Saturation. Timepoint: Daily. Method of measurement: Pulse oxymeter device.;Respiratory rate. Timepoint: Daily. Method of measurement: Counting the number of breaths per minute.;Leukocyte count. Timepoint: Every three days. Method of measurement: Cell counter device.;Lymphocyte percentage. Timepoint: Every three days. Method of measurement: Cell counter device.;Serum electrolites. Timepoint: Every three days. Method of measurement: Flame photometer device.;Quantitative C reactive Protein. Timepoint: Every three days. Method of measurement: Turbidometer device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Bijani

Qazvin University of Medical Sciences

dr.bijani@gmail.com+98 28 3335 4808

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026